Genmab Income Statement 2009-2025 | GNMSF

Revenue

$3,121.27

$2,392.025

$2,066.652

$1,349.486

$1,549.005

$804.363

$479.182

$359.31

$269.876

$168.597

Cost Of Goods Sold

$142.825

$32.815

Gross Profit

$2,978.445

$2,359.21

$2,066.652

$1,349.486

$1,549.005

$804.363

$479.182

$359.31

$269.876

$168.597

Research And Development Expenses

$1,413.46

$1,107.876

$787.579

$665.197

$480.588

$357.661

$226.696

$132.803

$98.206

$72.563

SG&A Expenses

$549.55

$478.724

$378.922

$204.125

$101.265

$51.266

$33.849

$22.327

$15.219

$13.574

Other Operating Income Or Expenses

$26.221

Operating Expenses

$2,006.51

$1,586.601

Operating Income

$971.935

$772.609

$900.151

$480.164

$967.151

$395.436

$218.637

$204.18

$156.451

$108.68

Total Non-Operating Income/Expense

$356.845

$45.883

$96.005

$153.532

$-62.659

$33.128

$36.699

$-42.601

$11.499

$4.04

Pre-Tax Income

$1,328.78

$818.492

$996.156

$633.695

$904.493

$428.564

$255.336

$161.579

$167.95

$112.72

Income Taxes

$191.4

$186.582

$214.241

$155.123

$175.567

$103.881

$22.149

$-6.05

$-8.449

$-0.891

Income After Taxes

$1,137.38

$631.91

$781.915

$478.573

$728.926

$324.683

$233.187

$167.629

$176.399

$113.611

Other Income

Income From Continuous Operations

$1,137.38

$631.91

$781.915

$478.573

$728.926

$324.683

$233.187

$167.629

$176.399

$113.611

Income From Discontinued Operations

Net Income

$1,137.38

$631.91

$781.915

$478.573

$728.926

$324.683

$233.187

$167.629

$176.399

$113.611

EBITDA

$1,031.82

$815.443

$951.411

$519.621

$1,006.83

$416.272

$218.637

$204.18

$156.451

$113.416

EBIT

$971.935

$772.609

$900.151

$480.164

$967.151

$395.436

$218.637

$204.18

$156.451

$108.68

Basic Shares Outstanding

Shares Outstanding

Basic EPS

$17.72

$9.68

$11.96

$7.32

$11.18

$5.16

$3.81

$2.76

$2.95

$1.94

EPS - Earnings Per Share

$17.60

$9.59

$11.84

$7.25

$11.06

$5.10

$3.76

$2.70

$2.86

$1.87